ADMA Biologics Stock Market Sentiment

ADMA
 Stock
  

USD 3.34  0.02  0.60%   

ADMA Biologics investor sentiment overview provides quick insight into current market opportunities from investing in ADMA Biologics. The current market sentiment together ADMA Biologics' historical and current headlines can help investors to time the market. Many technical investors use ADMA Biologics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please continue to ADMA Biologics Hype Analysis, ADMA Biologics Correlation and ADMA Biologics Performance.
  
ADMA Biologics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of ADMA Biologics daily returns and investor perception about the current pice of ADMA Biologics as well as its diversification or hedging effects on your existing portfolios.

ADMA Biologics Historical Sentiment

Although ADMA Biologics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding ADMA Biologics, such as negative comments on social media and news outlets, may cause fear in the market and push ADMA Biologics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of ADMA Biologics.
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use ADMA Biologics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward ADMA Biologics.

ADMA Biologics Sentiment by Major News Outlets

ADMA Biologics Historical Investor Sentiment

Investor biases related to ADMA Biologics' public news can be used to forecast risks associated with investment in ADMA Biologics. The trend in average sentiment can be used to explain how an investor holding ADMA Biologics can time the market purely based on public headlines and social activities around ADMA Biologics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
ADMA Biologics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ADMA Biologics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ADMA Biologics' news discussions. The higher the estimate score, the more favorable is the investor's outlook on ADMA Biologics.

ADMA Biologics Twitter Pulse

Investors have realized that leveraging social media to get the fastest information affecting stock prices isn't a theory anymore, it is a reality, and Twitter offers a platform that can outpace even the most trustworthy news aggregators. The influence of social media outlets on stock markets and stock prices of entities such as ADMA Biologics has been proven in recent years. We extract public sentiment from Twitter posts that could be utilized to determine whether ADMA Biologics' prices will increase or decrease.
Twitter's metrics such as likes, followers, and engagement can be good indicators of the reliance and probability of reaction to a specific tweet regarding ADMA Biologics. Our Twitter sentiment analysis of ADMA Biologics Stock helps investors make informed decisions by leveraging the power of the community. It is a perfect supplementary tool for any beginner or an experienced trader.
over two weeks ago at news.google.com         
Institutional investors are ADMA Biologics, Inc.s biggest bettors and were rewarded after last weeks...
news
over two weeks ago at news.google.com         
Biologics Co. Doubles Revenue in Q322 Trending Company - Streetwise Reports
news
over three weeks ago at news.google.com         
Mizuho Securities Adjusts Price Target on ADMA Biologics to 6 From 5, Maintains Buy Rating - Markets...
news
over a month ago at news.google.com         
Adma stock rises on FDA approval of North Carolina-based plasma collection center - Seeking Alpha
news
over a month ago at news.google.com         
ADMA Biologics, Inc. insiders have a reason to boast after seeing a US1.0m addition to their US580k ...
news
over a month ago at news.google.com         
Short Interest in ADMA Biologics, Inc. Rises By 6.0 percent - MarketBeat
news
over a month ago at news.google.com         
Will ADMA Biologics Inc Stay at the Top of the Healthcare Sector - InvestorsObserver
news
over a month ago at www.macroaxis.com         
Payment of 73678 shares by Brian Lenz of Adma Biologics subject to Rule 16b-3
Macroaxis News
over two months ago at news.google.com         
Should Biotechnology Stock ADMA Biologics Inc Be in Your Portfolio Monday - InvestorsObserver
news
over two months ago at news.google.com         
7 A-Rated Stocks Under 10 to Buy - InvestorPlace
news
over two months ago at simplywall.st         
Even though ADMA Biologics has lost US51m market cap in last 7 days, shareholders are still up 107 p...
Simply Wall St News at Macroaxis
over three months ago at www.benzinga.com         
ADMA Biologics , 12 Health Care Stocks Moving In Fridays Pre-Market Session - Benzinga
benzinga news
over three months ago at www.benzinga.com         
ADMA Biologics ADMA Biologics Earnings Outlook - Benzinga
benzinga news
over three months ago at seekingalpha.com         
ADMA Biologics Stock Strong Growth Is Clearing The Path To Profitability - Seeking Alpha
seekingalpha News
over three months ago at finance.yahoo.com         
Global plasma protein therapeutics market is projected to reach a market value of US59.58 billion in...
Yahoo News
Far too much social signal, news, headlines, and media speculation about ADMA Biologics that are available to investors today. That information is available publicly through ADMA Biologics media outlets and privately through word of mouth or via ADMA Biologics internal channels. However, regardless of the origin, that massive amount of ADMA Biologics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ADMA Biologics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ADMA Biologics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ADMA Biologics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ADMA Biologics alpha.

ADMA Biologics Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
7 A-Rated Stocks Under 10 to Buy - InvestorPlace09/23/2022
2
EPS Estimate09/30/2022
3
Payment of 73678 shares by Brian Lenz of Adma Biologics subj...10/04/2022
4
Will ADMA Biologics Inc Stay at the Top of the Healthcare Se...10/13/2022
5
Adma stock rises on FDA approval of North Carolina-based pla...10/31/2022
6
EPS Reported11/09/2022
7
Institutional investors are ADMA Biologics, Inc.s biggest be...11/14/2022
Please continue to ADMA Biologics Hype Analysis, ADMA Biologics Correlation and ADMA Biologics Performance. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for analysis

When running ADMA Biologics price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Is ADMA Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA Biologics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
661.2 M
Quarterly Revenue Growth YOY
0.99
Return On Assets
(0.11) 
Return On Equity
(0.69) 
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine ADMA Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.